Cognitive impairment

References

1. ↵
   1. Petersen RC,
   2. Smith GE,
   3. Waring SC,
   4. Ivnik RJ,
   5. Tangalos EG,
   6. Kokmen E

   (1999) Mild cognitive impairment:clinical characterization and outcome. Arch Neurol 56, 303–308.
2. ↵
   1. Mitchell AJ,
   2. Shiri-Feshki M

   (2009) Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119, 252–265.
3. ↵
   1. Birks J,
   2. Flicker L

   (2006) Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 3, CD006104.
4. ↵
   1. Buckley JS,
   2. Salpeter SR

   (2015) A Risk-Benefit Assessment of Dementia Medications:Systematic Review of the Evidence. Drugs Aging 32, 453–467.
5. ↵
   1. Williams-Gray CH,
   2. Evans JR,
   3. Goris A,
   4. Foltynie T,
   5. Ban M,
   6. Robbins TW,
   7. et al.

   (2009) The distinct cognitive syndromes of Parkinson’s disease:5 year follow-up of the CamPaIGN cohort. Brain 132, 2958–2969.
6. ↵
   1. Chare L,
   2. Hodges JR,
   3. Leyton CE,
   4. McGinley C,
   5. Tan RH,
   6. Kril JJ,
   7. et al.

   (2014) New criteria for frontotemporal dementia syndromes:clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry 85, 865–870.